This model carries human APP Swedish and PSEN1 ΔE9 mutations and develops a broad spectrum of AD-like pathology, including amyloid plaques, tau pathology, synaptic loss, gliosis, and age-related cognitive deficits, more closely mirroring human disease progression than many mouse models [57,58]. The gene discussed is MAPT; the disease is Alzheimer disease.